Bill Text: HI SB2270 | 2018 | Regular Session | Introduced
Bill Title: Relating To Prescription Medications.
Spectrum: Partisan Bill (Democrat 6-0)
Status: (Introduced - Dead) 2018-01-22 - Referred to CPH, WAM. [SB2270 Detail]
Download: Hawaii-2018-SB2270-Introduced.html
|
THE SENATE |
S.B. NO. |
2270 |
|
TWENTY-NINTH LEGISLATURE, 2018 |
|
|
|
STATE OF HAWAII |
|
|
|
|
|
|
|
|
||
|
|
||
A BILL FOR AN ACT
relating to prescription medications.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:
SECTION 1. Chapter 431, Hawaii Revised Statutes, is amended by adding a new section to article 10A to be appropriately designated and to read as follows:
"§431:10A- Prescription
medications; opioid dependency; copayment or coinsurance; exemption. (a)
Each policy of accident and health or sickness insurance issued or
renewed in this State that provides prescription drug coverage shall exempt
prescriptions for opioid dependency treatment medications from any copayment or
coinsurance provisions that may apply to those prescriptions in the policy.
(b) This section shall not apply to limited
benefit health insurance as provided pursuant to section 431:10A-102.5.
(c) For the purposes of this section:
"Buprenorphine" means a
schedule III drug included in section 329-18, which is used in the treatment of
opioid dependency.
"Naloxone" means a prescription
medication approved by the federal Food and Drug Administration that is used in
the treatment of opioid dependency.
"Opioid dependency treatment
medications" means:
(1) Naloxone; or
(2) Prescription medications
that contain buprenorphine and naloxone as active ingredients and are used in
the treatment of opioid dependency."
SECTION 2. Chapter 432, Hawaii Revised Statutes, is amended by adding a new section to article 1 to be appropriately designated and to read as follows:
"§432:1- Prescription
medications; opioid dependency; copayment or coinsurance; exemption. (a)
Each individual and group hospital or medical service plan contract
issued or renewed in this State that provides prescription drug coverage shall
exempt prescriptions for opioid dependency treatment medications from any
copayment or coinsurance provisions that may apply to those prescriptions in
the plan contract.
(b) This section shall not apply to limited
benefit health insurance as provided pursuant to section 431:10A-102.5.
(c) For the purposes of this section:
"Buprenorphine" means a
schedule III drug included in section 329-18, which is used in the treatment of
opioid dependency.
"Naloxone" means a
prescription medication approved by the federal Food and Drug Administration
that is used in the treatment of opioid dependency.
"Opioid dependency treatment
medications" means:
(1) Naloxone; or
(2) Prescription medications that contain buprenorphine and naloxone as active ingredients and are used in the treatment of opioid dependency."
SECTION 3. Chapter 432D, Hawaii Revised Statutes, is amended by adding a new section to be appropriately designated and to read as follows:
"§432D- Prescription
medications; opioid dependency; copayment or coinsurance; exemption. (a)
Each policy, contract, plan, or agreement issued or renewed in this
State that provides prescription drug coverage shall exempt prescriptions for opioid
dependency treatment medications from any copayment or coinsurance provisions
that may apply to those prescriptions in the policy, contract, plan, or
agreement.
(b) This section shall not apply to limited
benefit health insurance as provided pursuant to section 431:10A-102.5.
(c) For the purposes of this section:
"Buprenorphine" means a
schedule III drug included in section 329-18, which is used in the treatment of
opioid dependency.
"Naloxone" means a
prescription medication approved by the federal Food and Drug Administration
that is used in the treatment of opioid dependency.
"Opioid dependency treatment
medications" means:
(1) Naloxone; or
(2) Prescription medications that contain buprenorphine and naloxone as active ingredients and are used in the treatment of opioid dependency."
SECTION 4. New statutory material is underscored.
SECTION 5. This Act shall take effect upon its approval.
|
INTRODUCED BY: |
_____________________________ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Report Title:
Prescription Medications; Opioid Dependency; Treatment; Naloxone; Copayments; Coinsurance
Description:
Exempts prescriptions for opioid dependency treatment medications from any copayment or coinsurance provisions that may apply in a policy, plan, contract, or agreement that offers prescription drug coverage.
The summary description
of legislation appearing on this page is for informational purposes only and is
not legislation or evidence of legislative intent.
